乳腺癌筛查测试市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

乳腺癌筛查测试市场按测试(基因组测试和成像测试)和地理划分。

市场快照

Breast Cancer Screening Tests Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.5 %
Breast Cancer Screening Tests Market Size

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

乳腺癌筛查测试市场预计在预测期内的复合年增长率为 4.5%。导致该市场增长的因素包括对早期发现乳腺癌的认识不断提高、乳腺癌发病率不断增加以及政府举措和支持的增加。

早期发现乳腺癌可以带来理想的结果,包括提高生存率、治疗选择的数量和生活质量的提高。乳腺癌发病率的上升正在帮助市场在预测期内增长。根据 Breastcancer.org 的数据,大约八分之一的美国女性(约 12.4%)将在其一生中患上浸润性乳腺癌。到 2020 年,预计仅在美国将诊断出 276,480 例新的浸润性乳腺癌病例,以及 48,530 例新的非浸润性乳腺癌病例。由于发展中国家和发达国家对乳腺癌筛查测试的需求不断增加,因此对乳腺癌筛查测试的需求也在增加,这导致了这个市场的增长。

报告范围

进行乳腺癌筛查是为了在早期阶段发现癌症,并确保对患者进行及时治疗。根据癌变的乳腺细胞的类型,有不同类型的乳腺癌。乳腺癌会影响乳房的不同部位,例如导管和肺叶。

Report scope can be customized per your requirements. Click here.

主要市场趋势

影像学测试有望在乳腺癌筛查测试领域占据主导地位

最常用的乳腺癌筛查测试是影像学检查,这些影像学检查被认为是最可靠的。乳房 X 线照片是筛查乳腺癌的最广泛使用的测试。由于乳房 X 光检查是用于筛查乳腺癌的黄金标准技术,因此世界各地的政府和其他医疗保健组织正在采取措施为 50 至 75 岁的女性提供接受乳房 X 光检查的机会。这增加了全球对乳房 X 线照相术的需求,而实验室和血液测试以及其他成像测试越来越受欢迎。数字乳房断层合成可以提高乳房 X 光检查的诊断准确性,并用于评估模棱两可或可疑的乳房 X 线检查结果。其他方式,

Breast Cancer Screening Tests Market Report

北美在市场上占主导地位,预计在预测期内也会如此

北美目前在乳腺癌筛查测试市场上占主导地位,预计将在未来几年继续占据主导地位。在北美地区,美国占有最大的市场份额。这主要归因于乳腺癌发病率的上升和人们对癌症早期发现的认识不断提高。发达的医疗保健基础设施的存在预计将推动美国市场。

Breast Cancer Screening Tests Industry

竞争格局

乳腺癌筛查测试市场竞争适度,由几个主要参与者组成。在市场份额方面,一些主要参与者目前主导着市场。随着人群意识的提高和筛查测试的不断进步,预计其他一些较小的参与者将进入市场并可能占据相当大的份额。该市场的一些主要参与者包括 Allengers、Biocrates Life Sciences AG、Myriad Genetics、Hologic Inc. 和 Siemens Healthineers 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Awareness about Early Detection of Breast Cancer

      2. 4.2.2 Growing Incidence of Breast Cancer

      3. 4.2.3 Increasing Government Initiatives and Support

    3. 4.3 Market Restraints

      1. 4.3.1 Controversies Related to Mammography

      2. 4.3.2 High Cost of Screening Tests in the Developing Countries

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test

      1. 5.1.1 Genomic Tests

      2. 5.1.2 Imaging Test

        1. 5.1.2.1 Mammograms

        2. 5.1.2.2 Ultrasound

        3. 5.1.2.3 MRI

        4. 5.1.2.4 Tomography

        5. 5.1.2.5 Other Imaging Tests

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 US

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 UK

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle East & Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East & Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan plc

      2. 6.1.2 Myriad Genetics

      3. 6.1.3 Koninklijke Philips N.V.,

      4. 6.1.4 Carestream Health

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Fujifilm Holdings Corporation

      7. 6.1.7 NanoString Technologies, Inc.

      8. 6.1.8 Siemens Healthineers

      9. 6.1.9 Hologic Inc.

      10. 6.1.10 Quest Diagnostics Incorporated

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Breast Cancer Screening Test Market market is studied from 2018 - 2026.

The Breast Cancer Screening Test Market is growing at a CAGR of 4.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Allengers Medical Systems Limited, Myriad Genetics, Siemens Healthineers, Hologic Inc., GENERAL ELECTRIC COMPANY are the major companies operating in Breast Cancer Screening Test Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!